These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 24393214)
1. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions. Kuo JC; Hawkins C; Yip D Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214 [TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization. Wong JT; Ling M; Patil S; Banerji A; Long A J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767 [TBL] [Abstract][Full Text] [Related]
3. Evaluation and management of hypersensitivity reactions to chemotherapy agents. Tham EH; Cheng YK; Tay MH; Alcasabas AP; Shek LP Postgrad Med J; 2015 Mar; 91(1073):145-50. PubMed ID: 25659930 [TBL] [Abstract][Full Text] [Related]
4. Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposure. Lee SY; Kang HR; Song WJ; Lee KH; Han SW; Cho SH Cancer Chemother Pharmacol; 2014 May; 73(5):1021-9. PubMed ID: 24696124 [TBL] [Abstract][Full Text] [Related]
5. Review of hypersensitivity reactions to antineoplastic agents. Cortijo-Cascajares S; Jiménez-Cerezo MJ; Herreros de Tejada A Farm Hosp; 2012; 36(3):148-58. PubMed ID: 22484106 [TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492 [TBL] [Abstract][Full Text] [Related]
7. Desensitization regimens for drug allergy: state of the art in the 21st century. Liu A; Fanning L; Chong H; Fernandez J; Sloane D; Sancho-Serra M; Castells M Clin Exp Allergy; 2011 Dec; 41(12):1679-89. PubMed ID: 21883538 [TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment. Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576 [TBL] [Abstract][Full Text] [Related]
9. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions. Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998 [TBL] [Abstract][Full Text] [Related]
10. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century. Castells Guitart MC J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769 [TBL] [Abstract][Full Text] [Related]
11. Rapid desensitization for hypersensitivity reactions to chemotherapy agents. Castells M Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867 [TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies. Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154 [TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol. Syrigou E; Dannos I; Kotteas E; Makrilia N; Tourkantonis I; Dilana K; Gkiozos I; Saif MW; Syrigos KN Int Arch Allergy Immunol; 2011; 156(3):320-4. PubMed ID: 21720178 [TBL] [Abstract][Full Text] [Related]
14. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233 [TBL] [Abstract][Full Text] [Related]
15. Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions. Vetter MH; Khan A; Backes FJ; Bixel K; Cohn DE; Copeland LJ; Fowler JM; Salani R; Li Q; O'Malley DM Gynecol Oncol; 2019 Feb; 152(2):316-321. PubMed ID: 30503265 [TBL] [Abstract][Full Text] [Related]
16. Aspirin desensitisation for Chinese patients with coronary artery disease. Lee JK; Tsui KL; Cheung CY; Chau CH; Chan HL; Wu KL; Cheung GS; Choi MC; Chan KK; Li SK Hong Kong Med J; 2013 Jun; 19(3):207-13. PubMed ID: 23650199 [TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes of rapid desensitisation protocols. van Nunen S Intern Med J; 2014 May; 44(5):431-3. PubMed ID: 24816305 [No Abstract] [Full Text] [Related]
18. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Lee C; Gianos M; Klaustermeyer WB Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063 [TBL] [Abstract][Full Text] [Related]
19. Rapid desensitization of hypersensitivity reactions to chemotherapy agents. Castells M Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934 [TBL] [Abstract][Full Text] [Related]
20. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity. Limsuwan T; Castells MC Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]